Valuation: Futura Medical plc

Market Cap 1.8M 2.42M 2.12M 1.96M 3.4M 233M 3.47M 23.37M 9.19M 114M 9.11M 8.91M 394M P/E 2024
77.2x
P/E 2025 -0.4x
Enterprise Value -1.6M -2.15M -1.88M -1.74M -3.01M -207M -3.08M -20.74M -8.16M -101M -8.08M -7.9M -349M EV / Sales 2024
6,428,637x
EV / Sales 2025 1,815,433x
Free-Float
83.88%
Yield 2024 *
-
Yield 2025 -
1 day+0.03%
1 week-16.19%
Current month-40.37%
1 month-51.55%
3 months-74.05%
6 months-74.41%
Current year-72.19%
1 week 0.3
Extreme 0.301
0.5
1 month 0.24
Extreme 0.244
0.7
Current year 0.24
Extreme 0.244
1.75
1 year 0.24
Extreme 0.244
14.85
3 years 0.24
Extreme 0.244
57
5 years 0.24
Extreme 0.244
67
10 years 0.24
Extreme 0.244
95.6
Manager TitleAgeSince
Chief Executive Officer 56 2025-08-07
Director of Finance/CFO 46 2018-02-19
Chief Tech/Sci/R&D Officer 74 2016-11-15
Director TitleAgeSince
Director/Board Member 74 2016-03-31
Director/Board Member 46 2018-02-19
Chairman 69 -
Date Insider Type Main position Quantity % Market Cap.
12/8/25 Buy

Chief Financial Officer

500,000 0.1488%
12/8/25 Buy

Chief Executive Officer

5,000,000 1.4876%
12/8/25 Buy

Chief Technology Officer

500,000 0.1488%
Change 5-day change 1-year change 3-year change Capi.($)
+0.03%-16.19%-97.37%-99.38% 2.42M
-1.09%-2.08%+54.00%+55.35% 53.83B
-7.17%-4.39%+42.72%+73.70% 52.1B
+0.80%-6.31%+5.62%+413.12% 23.48B
-0.09%-0.01%-16.85%-16.17% 23.13B
+3.46%+2.52%+36.64%-5.41% 19.36B
-0.12%-1.84%+34.28%-32.52% 17.56B
-5.16%-7.00%+168.44%+291.24% 15.2B
+3.62%0.00%+33.47%+643.91% 14.83B
+0.43%-1.03%+25.75%+186.18% 14.06B
Average -0.53%-1.01%+28.67%+151.00% 23.36B
Weighted average by Cap. -1.58%-2.36%+41.12%+137.28%

Financials

2024 2025
Net sales 13.93 18.74 16.37 15.11 26.25 1.8K 26.83 180.58 71.03 883.64 70.36 68.82 3.04K 1.7 2.28 1.99 1.84 3.2 219.82 3.27 22 8.65 107.66 8.57 8.38 370.61
Net income 1.29M 1.74M 1.52M 1.4M 2.44M 168M 2.49M 16.77M 6.59M 82.04M 6.53M 6.39M 282M -9.07M -12.2M -10.66M -9.84M -17.1M -1.18B -17.48M -118M -46.26M -576M -45.83M -44.82M -1.98B
Net Debt -6.6M -8.87M -7.76M -7.16M -12.43M -855M -12.71M -85.53M -33.64M -419M -33.33M -32.6M -1.44B -3.4M -4.58M -4M -3.69M -6.41M -441M -6.55M -44.11M -17.35M -216M -17.19M -16.81M -743M
Logo Futura Medical plc
Futura Medical plc is a consumer healthcare company that specializes in the development and global commercialization of sexual health products. The Company is a developer of sexual health products, including the lead product, Eroxon, and two products in development, including WSD4000 and Eroxon Intense. Eroxon is a clear gel used for the treatment of erectile dysfunction (ED) available over the counter and without prescription and addresses significant unmet needs in the ED market. Eroxon Intense provides a potential range extension of the Eroxon product and acts as an additional treatment option for men who have ED. WSD4000 is a topical treatment designed for sexual dysfunction in women. The Company has distribution partners in place in a number of major consumer markets, including Haleon in the United States, and Cooper Consumer Health in Europe.
Employees
13
Date Price Change Volume
26-07-20 GBX 0.3101 +0.03% 1,005,443
26-07-17 GBX 0.3100 -22.50% 2,736,607
26-07-16 GBX 0.4000 +11.11% 8,094,994
26-07-15 GBX 0.3600 0.00% 3,587,949
26-07-14 GBX 0.3600 -2.70% 1,549,909

Annual profits - Rate of surprise